New approaches for modeling radiopharmaceutical pharmacokinetics using continuous distributions of rates

Igor Shuryak, Ekaterina Dadachova

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Radiopharmaceutical pharmacokinetics are usually approximated by sums of discrete first-order rates, using 3 or more parameters. We hypothesized that pharmacokinetic processes can be modeled even better by continuous probability distributions (CPD) of rates, using only 1-2 parameters. Methods: To test this hypothesis, we used biodistribution data for 188Re-labeled melanin-specific antibody in blood, kidneys, liver, bone marrow, and lungs of melanoma xenograft-bearing mice. We used 3 discrete-rate models (monoexponential, monoexponential with constant, and biexponential) and 4 CPD models (stretched-exponential, modified stretched-exponential, simplified versions of stretched-exponential, and modified stretched-exponential). They were compared by sample-size-corrected Akaike information criterion. Total time integrals of radioactivity were computed for each model and averaged across all models. Results: The ratio of weights of evidence for CPD versus discrete-rate models was high for blood (12.2) and lungs (2.7), almost unity (0.99) for bone marrow, and slightly lower for kidneys (0.81) and liver (0.73). In all organs or tissues except lungs, model-averaged time integrals were 12.7%-54.0% higher than biexponential model estimates. Conclusion: Simple CPD models often outperform more complex discrete-rate models on pharmacokinetic data. Radioactivity time integrals are more robustly estimated by multimodel inference than using any single model.

Original languageEnglish (US)
Pages (from-to)1622-1628
Number of pages7
JournalJournal of Nuclear Medicine
Volume56
Issue number10
DOIs
StatePublished - Oct 1 2015

Fingerprint

Radiopharmaceuticals
Pharmacokinetics
Lung
Radioactivity
Bone Marrow
Kidney
Liver
Melanins
Heterografts
Sample Size
Melanoma
Weights and Measures
Antibodies

Keywords

  • Biodistribution
  • Model
  • Pharmacokinetics
  • Radiopharmaceutical

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

New approaches for modeling radiopharmaceutical pharmacokinetics using continuous distributions of rates. / Shuryak, Igor; Dadachova, Ekaterina.

In: Journal of Nuclear Medicine, Vol. 56, No. 10, 01.10.2015, p. 1622-1628.

Research output: Contribution to journalArticle

@article{1c37503577a64e9b87e27a0e2f7a15e1,
title = "New approaches for modeling radiopharmaceutical pharmacokinetics using continuous distributions of rates",
abstract = "Radiopharmaceutical pharmacokinetics are usually approximated by sums of discrete first-order rates, using 3 or more parameters. We hypothesized that pharmacokinetic processes can be modeled even better by continuous probability distributions (CPD) of rates, using only 1-2 parameters. Methods: To test this hypothesis, we used biodistribution data for 188Re-labeled melanin-specific antibody in blood, kidneys, liver, bone marrow, and lungs of melanoma xenograft-bearing mice. We used 3 discrete-rate models (monoexponential, monoexponential with constant, and biexponential) and 4 CPD models (stretched-exponential, modified stretched-exponential, simplified versions of stretched-exponential, and modified stretched-exponential). They were compared by sample-size-corrected Akaike information criterion. Total time integrals of radioactivity were computed for each model and averaged across all models. Results: The ratio of weights of evidence for CPD versus discrete-rate models was high for blood (12.2) and lungs (2.7), almost unity (0.99) for bone marrow, and slightly lower for kidneys (0.81) and liver (0.73). In all organs or tissues except lungs, model-averaged time integrals were 12.7{\%}-54.0{\%} higher than biexponential model estimates. Conclusion: Simple CPD models often outperform more complex discrete-rate models on pharmacokinetic data. Radioactivity time integrals are more robustly estimated by multimodel inference than using any single model.",
keywords = "Biodistribution, Model, Pharmacokinetics, Radiopharmaceutical",
author = "Igor Shuryak and Ekaterina Dadachova",
year = "2015",
month = "10",
day = "1",
doi = "10.2967/jnumed.115.160515",
language = "English (US)",
volume = "56",
pages = "1622--1628",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "10",

}

TY - JOUR

T1 - New approaches for modeling radiopharmaceutical pharmacokinetics using continuous distributions of rates

AU - Shuryak, Igor

AU - Dadachova, Ekaterina

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Radiopharmaceutical pharmacokinetics are usually approximated by sums of discrete first-order rates, using 3 or more parameters. We hypothesized that pharmacokinetic processes can be modeled even better by continuous probability distributions (CPD) of rates, using only 1-2 parameters. Methods: To test this hypothesis, we used biodistribution data for 188Re-labeled melanin-specific antibody in blood, kidneys, liver, bone marrow, and lungs of melanoma xenograft-bearing mice. We used 3 discrete-rate models (monoexponential, monoexponential with constant, and biexponential) and 4 CPD models (stretched-exponential, modified stretched-exponential, simplified versions of stretched-exponential, and modified stretched-exponential). They were compared by sample-size-corrected Akaike information criterion. Total time integrals of radioactivity were computed for each model and averaged across all models. Results: The ratio of weights of evidence for CPD versus discrete-rate models was high for blood (12.2) and lungs (2.7), almost unity (0.99) for bone marrow, and slightly lower for kidneys (0.81) and liver (0.73). In all organs or tissues except lungs, model-averaged time integrals were 12.7%-54.0% higher than biexponential model estimates. Conclusion: Simple CPD models often outperform more complex discrete-rate models on pharmacokinetic data. Radioactivity time integrals are more robustly estimated by multimodel inference than using any single model.

AB - Radiopharmaceutical pharmacokinetics are usually approximated by sums of discrete first-order rates, using 3 or more parameters. We hypothesized that pharmacokinetic processes can be modeled even better by continuous probability distributions (CPD) of rates, using only 1-2 parameters. Methods: To test this hypothesis, we used biodistribution data for 188Re-labeled melanin-specific antibody in blood, kidneys, liver, bone marrow, and lungs of melanoma xenograft-bearing mice. We used 3 discrete-rate models (monoexponential, monoexponential with constant, and biexponential) and 4 CPD models (stretched-exponential, modified stretched-exponential, simplified versions of stretched-exponential, and modified stretched-exponential). They were compared by sample-size-corrected Akaike information criterion. Total time integrals of radioactivity were computed for each model and averaged across all models. Results: The ratio of weights of evidence for CPD versus discrete-rate models was high for blood (12.2) and lungs (2.7), almost unity (0.99) for bone marrow, and slightly lower for kidneys (0.81) and liver (0.73). In all organs or tissues except lungs, model-averaged time integrals were 12.7%-54.0% higher than biexponential model estimates. Conclusion: Simple CPD models often outperform more complex discrete-rate models on pharmacokinetic data. Radioactivity time integrals are more robustly estimated by multimodel inference than using any single model.

KW - Biodistribution

KW - Model

KW - Pharmacokinetics

KW - Radiopharmaceutical

UR - http://www.scopus.com/inward/record.url?scp=84943150772&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943150772&partnerID=8YFLogxK

U2 - 10.2967/jnumed.115.160515

DO - 10.2967/jnumed.115.160515

M3 - Article

C2 - 26205297

AN - SCOPUS:84943150772

VL - 56

SP - 1622

EP - 1628

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 10

ER -